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Abstract: Endometriosis, one of the most common gynecological disorders, is a complex disease
characterized by the growth of endometrial-like tissue in extra-uterine locations and is a cause of
pelvic pain and infertility. Evidence from observational studies indicate that endometriosis usually
appears together with several other phenotypes. These include a list of autoimmune diseases, most
of them more prevalent in women, anthropometric traits associated with leanness in the adulthood,
as well as female reproductive traits, including altered hormone levels and those associated with
a prolonged exposure to menstruation. However, the biological mechanisms underlying their co-
morbidity remains unknown. To explore whether those phenotypes and endometriosis share a
common genetic origin, we performed a systematic Two-Sample Mendelian Randomization (2SMR)
analysis using public GWAS data. Our results suggest potential common genetic roots between
endometriosis and female anthropometric and reproductive traits. Particularly, our data suggests
that reduced weight and BMI might be mediating the genetic susceptibility to suffer endometriosis.
Furthermore, data on female reproductive traits strongly suggest that genetic variants that predispose
to a more frequent exposure to menstruation, through earlier age at menarche and shorter menstrual
cycles, might also increase the risk to suffer from endometriosis.
Keywords: endometriosis; mendelian randomization; comorbidities; autoimmune diseases; anthro-
pometric traits; female reproductive traits
1. Introduction
Endometriosis is a hormone-dependent inflammatory disorder characterized by the
presence and growth of endometrial-like tissue outside the uterus, causing pelvic pain and
impaired fertility [1]. Endometriosis-associated symptoms negatively impact the health and
quality of life of affected women, which represent approximately 10% of reproductive-aged
females, and up to 50% of women with fertility problems [2]. Besides, currently available
pharmacological and surgical treatments are clearly inefficient [3].
The presentation of endometriosis is heterogeneous, and a wide variety of phenotypes
appear in women with the disease [4]. In this sense, co-morbidity between endometriosis
and autoimmune diseases has been consistently reported [5–7]. A recent meta-analysis of
population-based cross-sectional, case-control, and cohort studies identified statistically
significant associations between endometriosis and celiac disease, systemic lupus erythe-
matosus, Sjögren’s syndrome, rheumatoid arthritis, multiple sclerosis and inflammatory
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bowel disease [8]. However, whether these immune-mediated diseases and endometriosis
share common genetic origin or arise independently remains unknown.
Similarly, endometriosis has been associated with leanness and tallness in adult-
hood [9]. An increased odds of endometriosis has been linked to taller height [10], and
inverse association between endometriosis and adult body mass index (BMI) has been re-
ported [11,12]. In line with these observations, an opposite correlation between endometrio-
sis and body fat distribution (measured as waist-to-hip ratio) has been described [13]. Inter-
estingly, a genome-wide enrichment analysis identified shared loci between endometriosis
and body fat distribution, but not with BMI [14], suggesting distinct mechanisms that might
explain the association between each associated anthropometric trait and endometriosis.
Finally, a few, though robust risk factors frequently appear in women with endometrio-
sis. On the one hand, hormone imbalance, mainly estrogen dominance [15] and proges-
terone resistance [16], are commonly observed in affected females; similarly, reduced levels
of anti-Müllerian hormone (AMH) have been described in women with endometriomas [17].
On the other hand, probably as a consequence of increased exposure to menstruation, early
age at menarche as well as short menstrual cycles have been associated with a greater risk
of suffering from endometriosis [18,19]. Whether these associations share common genetic
origins, though, remains largely unexplored.
Both endometriosis itself and the associated phenotypes are complex traits, influenced
not only by environmental, but also by genetic factors. In the last decade, genome-wide
association studies (GWASs) have identified single nucleotide polymorphisms (SNPs)
that mediate susceptibility to suffer from those conditions. GWASs investigate complex
traits using either case–control or cohort study designs, and results are usually deposited
in public repositories such as the GWAS catalog or IEU GWAS database. These public
GWAS results can be analyzed using Two-Sample Mendelian Randomization (2SMR), a
statistical tool that enables the identification of causal and pleiotropic genetic associations
between an exposure and an outcome using SNPs as instrumental variables. In the context
of this work, we employed 2SMR to systematically study genetic associations between
endometriosis-related phenotypes, and the disease itself.
2. Materials and Methods
2.1. Literature Search and GWAS Data Sources
Based on the published literature, we selected a list of phenotypes that have been
associated with endometriosis, and classified them into three categories: (a) Autoimmune
diseases (celiac disease, systemic lupus erythematosus, Sjögren’s syndrome, rheumatoid
arthritis, and multiple sclerosis), (b) Anthropometric traits (weight, height, body mass in-
dex, waist-to-hip ratio), (c) Female reproductive traits, including reproductive hormone lev-
els (dehydroepiandrosterone sulphate, estradiol, free androgen index, follicle-stimulating
hormone, luteinizing hormone, prolactin, progesterone, sex hormone-binding globulin,
testosterone, anti-Müllerian hormone) and menstruation-related traits (age at menarche,
age at menopause, length of menstrual cycle, and excessive and frequent menstruation).
For each of the selected traits, we conducted an extensive search in the public repositories
NHGRI-EBI GWAS catalog (https://www.ebi.ac.uk/gwas/) and IEU GWAS database (https:
//gwas.mrcieu.ac.uk/) to select the most appropriate GWAS for each analysis (Table 1;
databases were accessed in November 2020). We prioritized GWASs with large sample-
sizes, cohorts of European ancestry, as well as exclusive female participation. Note that for
autoimmune diseases, there was no female-only GWAS available, so we used male-female
GWAS instead. For menstrual traits, we used Ben Elsworth’s UK Biobank genomic data, as
these studies comprised the largest sample sizes.
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Table 1. Phenotypes analyzed and GWASs selected as exposure/outcome data for 2SMR analysis.











Celiac disease (CeD) GCST000612
15,283




120,873 28714469 [21] No(6,748/11,516)
Sjören’s syndrome (SS) GCST005532
4175
648,937 24097067 [22] No(1,541/2,634)
Rheumatoid arthritis (RA) ieu-a-832
58,284
8,747,963 24390342 [23] No(14,361/43,923)
Multiple sclerosis (MS) GCST005531
38,589
161,311 24076602 [24] No(14,498/24,091)
Anthropometric traits
Weight ieu-a-107 73,137 2,747,007 23754948 [25] Yes
Height ieu-a-97 73,137 2,748,546 23754948 [25] Yes
Body Mass Index (BMI) ieu-a-974 171,977 2,494,613 25673413 [26] Yes
Waist-To-Hip ratio (WTH) ieu-a-75 118,003 2,466,102 25673412 [27] Yes
Female reproductive traits
Reproductive hormone levels 2 GCST002925 2913 7,879,351 26014426 [28] Yes 3
AMH levels GCST007363 3344 ≈8,400,000 30649302 [29] Yes
Age at menarche ukb-b-3768 243,944 9,851,867 UKBB (B.Elsworth) Yes
Age at menopause ukb-b-17422 143,819 9,851,867 UKBB (B.Elsworth) Yes
















1 In cases where the GWAS did not have a case-control design, only the sample size is displayed. 2 Measured reproductive hormones in
GCST002925 GWAS are dehydroepiandrosterone sulphate (DHEAS), estradiol, free androgen index (FAI), follicle-stimulating hormone
(FSH), luteinizing hormone (LH), prolactin, progesterone, sex hormone-binding globulin and testosterone. 3 From the total number of
individuals in this GWAS (2913), the vast majority (2619) were women.
2.2. Two-Sample Mendelian Randomization (2SMR) Analysis
Two-Sample Mendelian Randomization (2SMR) analysis was performed according
to the developers’ guidelines (https://mrcieu.github.io/TwoSampleMR/index.html) us-
ing the TwoSampleMR R package. Figure 1 displays the analysis pipeline, detailing the
commands used to perform each step.
GWASs selected to be used as exposure data (Table 1) were queried in the MR-base
platform available in RStudio, and formatted using either the format_data (for studies from
GWAS catalog) or extract_instruments (for studies from IEU GWAS database) functions in R.
Once the instruments from the GWAS catalog were identified, the clump_data function was
applied to ensure they were independent; instruments extracted from IEU GWAS database
do not need linkage disequilibrium formatting since they have already been clumped.
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Figure 1. Analysis pipeline used for 2SMR. Exposure data were obtained from either GWAS cata-
log or IEU GWAS database and formatted and clumped when necessary. Outcome data were ob-
tained from endometriosis FinnGen cohort and formatted to meet 2SMR requirements. Both expo-
sure and outcome datasets were harmonized before performing the 2SMR analysis for all SNPs 
and for each SNP separately. Functions used in each case are indicated. 
GWASs selected to be used as exposure data (Table 1) were queried in the MR-base 
platform available in RStudio, and formatted using either the format_data (for studies from 
GWAS catalog) or extract_instruments (for studies from IEU GWAS database) functions in 
R. Once the instruments from the GWAS catalog were identified, the clump_data function 
was applied to ensure they were independent; instruments extracted from IEU GWAS 
database do not need linkage disequilibrium formatting since they have already been 
clumped. 
Complete endometriosis GWAS summary statistics used to prepare the outcome data 
were obtained from the FinnGen cohort available in the IEU GWAS database using the 
extract_outcome_data function in R. The FinnGen study uses samples collected by a nation-
wide network of Finnish biobanks and combines genomic information with health care 
data including endometriosis status (https://finngen.gitbook.io/documentation/). Specifi-
cally, the GWAS with reference ID finn-a-N14_ENDOMETRIOSIS was used (N14 refers to 
diseases of the genitourinary system), comprising 3380 cases and 31,753 controls, with a 
total number of 16,152,119 genotyped SNPs (Table 1).  
Exposure and outcome data were subsequently harmonized using the harmonise_data 
function in R. This step is fundamental to ensure that effect and standard error on the 
exposure and the outcome correspond to the same effect alleles.  
The generated datasets were analyzed with the mr function in R using a range of 
methods available in the 2SMR package, including weighted median (WM), MR-Egger 
(MRE) and inverse variance weighted (IVW) estimates [30]. The WM method calculates 
Wald ratios for each of the instruments and select the median value as the causal stimate; 
it provides valid estimates when more than half of the SNPs satisfy the instrumental var-
iable assumptions. The MRE method calculates Wald ratios for each of the instruments 
and combines the results using an adapted Egger regression; it returns an unbiased causal 
effect even if the assumption of no horizontal pleiotropy is violated for all SNPs. The IVW 
method treats each SNP as a valid natural experiment, calculates the Wald ratio for each 
Figure 1. nalysis pipeline used for 2S . Exposure data ere obtained fro either AS catalog
r IEU GWAS database nd formatted and clumped when necessary. Outcome data were obtained
from endometri sis FinnGen cohort and formatted to mee 2SMR requirements. Both exposure and
outcome datasets were harmonized before performing the 2SMR analysis for all SNPs and for each
SNP separately. Functions used in each case are indicated.
Complet ndometriosis GWAS summary statistics us d to p epare outcom
d ta were obt in d from the Fi nGen cohort available in the IEU GWAS databas using
the extract_ utc me_data function in R. The FinnGen study uses samples collected by a
nationwide network of Finnish biobanks and combines genomic information with health
care data includi g endometriosis status (https://finnge .gitbook.io/documentation/).
Specifically, the GWAS with reference ID finn-a-N14_ENDOMETRIOSIS was used (N14
refers to diseases of the genitourinary system), comprising 3380 cases and 31,753 controls,
with a total number of 16,152,119 genotyped SNPs (Table 1).
Exposure and outcome data were subsequently harmonized using the harmonise_data
function in R. This step is fundamental to ensure that effect and standard error on the
exposure and the outcome correspond to the same effect alleles.
The generated datasets were analyzed with the mr function in R using a range of
methods available in the 2SMR package, including weighted median (WM), MR-Egger
(MRE) and inverse variance weighted (IVW) estimates [30]. The WM method calculates
Wald ratios for each of the instruments and select the median value as the causal stimate; it
provides valid estimates when more than half of the SNPs satisfy the instrumental variable
assumptions. The MRE method calculates Wald ratios for each of the instruments and
combines the results using an adapted Egger regression; it returns an unbiased causal
effect even if the assumption of no horizontal pleiotropy is violated for all SNPs. The IVW
method treats each SNP as a valid natural experiment, calculates the Wald ratio for each of
them and combines the results using an IVW meta-analysis approach; the slope from this
approach can be interpreted as the causal effect of the exposure on the outcome [31].
Scatter plots were generated with the mr_scatter_plot function in R. Beta values were
reformatted to calculate Odds Ratios (OR) and 95% Confidence Intervals (CI) to generate a
forest plot for each method using the forestplot R package.
In addition, we obtained MR estimates of single SNPs using the mr_singlesnp function
in R, which applies the Wald ratio method by default. Forest plots were generated with the
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mr_forest_plot function in R. The multiple-testing-adjusted p-value, (false discovery rate,
FDR) was calculated with the Benjamini–Hochberg procedure with the function p.adjust of
the stats package in R.
3. Results
3.1. Overall 2SMR Estimates between Autoimmune Diseases, Anthropometric Traits and Female
Reproductive Traits and Endometriosis
Endometriosis has been associated with multiple phenotypes, including a variety of
autoimmune diseases, anthropometric traits and female reproductive traits. In order to
determine whether these associations share a common genetic component, we performed
a systematic 2SMR analysis (Figure 1) where GWASs for associated phenotypes were
used as exposure data, and endometriosis GWAS from the FinnGen cohort as outcome
data (Table 1). Figure 2 shows Mendelian Randomization estimates (Odds Ratio, 95%
Confidence Interval, p-value) for each analysis using the weighted median (WM), MR-
Egger (MRE) and inverse variance weighted (IVW) methods. The corresponding scatter
plots for each analysis are represented in Supplementary Materials Figure S1, where effect
sizes of the SNP-phenotype associations in the exposure and outcome data are plotted; in
those graphs, the slopes of the lines correspond to causal estimates using each of the three
different methods.
3.1.1. Autoimmune Diseases and Endometriosis
Our first 2SMR analysis searched for a shared genetic component between autoim-
mune diseases and endometriosis. For this analysis, we selected five autoimmune diseases—
celiac disease (CeD), systemic lupus erythematosus (SLE), Sjögren’s syndrome (SS), rheuma-
toid arthritis (RA), and multiple sclerosis (MS)—that have been previously associated with
increased susceptibility to endometriosis [8]; in our selection, we prioritized those au-
toimmune diseases that are more prevalent in women [32]. Note that in this analysis, no
female-exclusive GWAS was publicly available (Table 1). Overall 2SMR estimates show,
in most of the cases, non-significant p-values (Figure 2) and very small and not always
consistent effect-sizes (Figure 2, Supplementary Materials Figure S1), suggesting that the
selected autoimmune diseases and endometriosis susceptibility do not share a common
genetic origin. The only exception was multiple sclerosis (MS). Both MS and endometrio-
sis are pleiotropically associated (p = 0.017, weighted median method), suggesting that
they might share common genetic variants. According to the effect sizes reported, MS
genetic susceptibility could have a protective effect for endometriosis. Of note, even though
the other two methods (inverse variance weighted, MR-Egger) did not give significant
associations, they showed a similar, negative correlation between effect sizes (Figure 2,
Supplementary Materials Figure S1).
3.1.2. Anthropometric Traits and Endometriosis
In our second 2SMR approach, we included four anthropometric traits—weight,
height, body mass index (BMI), and Waist-To-Hip ratio (WTH)—that have been previously
associated with endometriosis [9–13] in observational studies. Since women differ substan-
tially from men regarding weight, height, and body fat mass and distribution (measured
as means of BMI and WTH ratio, respectively), we used data from GWASs conducted
separately in women for all the selected phenotypes [25–27] (Table 1). Scatter plots in
Figure S1 show that whereas SNPs related to weight and BMI display a negative correlation
with endometriosis, height and WTH ratio display a positive correlation. Importantly,
weight-endometriosis and BMI-endometriosis 2SMR analyses gave a significant overall
pleiotropic association using the IVW (p = 0.015) and MR-Egger (p = 0.009) methods, re-
spectively (Figure 2). Our results are in line with previous reports describing an association
between adult body leanness and endometriosis and provide a putative common genetic
origin of the described associations.
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Figure 2. Overall 2SMR estimates between selected exposure phenotypes for (a) autoimmune dis-
eases, (b) anthropometric traits and (c) female reproductive traits and endometriosis outcome.  
Estimates were calculated using the weighted median (WM), MR-Egger (MRE) and inverse vari-
ance weighted (IVW) methods. Effects are represented as Odds Ratio (OR) and 95% confidence 
interval (CI); significant associations (p-value < 0.05) are highlighted. AMH: Anti-Müllerian hor-
mone.  
3.1.1. Autoimmune Diseases and Endometriosis 
Figure 2. Overall 2SMR estimates between selected exposure phenotypes for (a) autoimmune
diseases, (b) anthropometric traits and (c) female reproductive traits and endometriosis outcome.
Estimates were calculat d using the weighted median (WM), MR-Egger (MRE) and inverse variance
weighted (IVW) methods. Effect are represented s Odds Ratio (OR) a d 95% confidence interval
(CI); significant associations (p-value < 0.05) are ighlighted. MH: Anti-Müllerian hormone.
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3.1.3. Female Reproductive Traits and Endometriosis
For our last 2SMR analysis, we selected female reproductive traits, including repro-
ductive hormone levels and menstruation-related traits, as indicated in Table 1. Genetic
instruments for reproductive hormone levels were obtained from a GWAS by Ruth et al.,
2016, where nine sex hormone levels [dehydroepiandrosterone sulphate (DHEAS), estra-
diol, free androgen index (FAI), follicle-stimulating hormone (FSH), luteinizing hormone
(LH), prolactin, progesterone, sex hormone-binding globulin and testosterone] were mea-
sured in almost 3000 individuals, the majority of them (≈90%) females [28]; in addition,
we included another GWAS that measured anti-Müllerian hormone (AMH) levels in pre-
menopausal women [29]. Whereas the 2SMR estimates calculated with the first study were
not significant, the one computed with AMH GWAS was significant in two out of the
three methods employed (WM p-value = 0.008; IVW p-value = 0.001) (Figure 2). Moreover,
scatter plots showed a negative slope in the three cases (Figure S1), suggesting a negative
correlation between the genetic instruments of the exposure (AMH levels) and the outcome
(endometriosis).
Regarding menstruation-related traits, Ben Elsworth’s UKBB data for age at menarche,
age at menopause, length of menstrual cycle and excessive and frequent menstruation were
selected. Note that for excessive and frequent menstruation only one SNP was selected
as instrumental variable, making it impossible to calculate overall 2SMR estimates or to
generate scatter plots. As shown in Figure 2, among the remaining three phenotypes, both
age at menarche and length of menstrual cycle resulted in significant overall associations
(p-value < 0.05), the latter being significant using the three methods (WM, MRE, IVW).
Notably, the scatter plot for length of menstrual cycle showed a negative correlation with
endometriosis (Supplementary Materials Figure S1), suggesting that SNPs that predispose
to have longer cycles protect from endometriosis.
3.2. Single SNP 2SMR Estimates of Significant Associations
For each of the selected phenotypes, we further analyzed the results at a single SNP
level. Single-SNP 2SMR estimates and SNP information are summarized in Supplementary
Table S1. In those cases in which overall 2SMR estimates gave significant association, we
represented the results using forest plots (Figure 3). Forest plots for multiple sclerosis,
weight, BMI and age at menarche show both positive and negative beta-values for indi-
vidual SNPs, indicating that the SNP effects could be variably consistent or contradictory
when compared to endometriosis. Interestingly, most of the SNPs predisposing to increased
AMH levels and longer menstrual cycles show negative beta-values, strongly suggesting
that the majority of the risk SNPs for those traits have the opposite effect in endometriosis
susceptibility. Moreover, in the particular case of the phenotype “length of menstrual
cycle”, global estimates gave consistently negative beta-values, with small standard errors
at the single-SNP level.
Finally, we decided to further explore the individual SNPs that arose from the single
SNP 2SMR analyses. In general, very few showed significant pleiotropic associations
mediating endometriosis and associated traits (Supplementary Table S1). Surprisingly,
three SNPs that are 25–40 Kb upstream the follicle-stimulating hormone beta subunit
(FSHB) gene promoter (namely rs11031002, rs11031005 and rs11031006) appeared to be
pleiotropically associated with endometriosis and four different female reproductive traits
(Table 2). In particular, these traits were sex hormone levels, age at menarche, age at
menopause and length of menstrual cycle. The correlation between those SNPs and
endometriosis was generally negative, suggesting a different risk allele predisposing to
endometriosis compared to the abovementioned female reproductive traits.
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Table 2. Single SNP 2SMR estimates b tween a number of exposure phenotypes and endometriosis that share FSHB gene as
the nearest T S.
Exposure Phenotype SNP Beta SE p-value FDR Nearest TSS
Sex hormone l v ls rs11031002 −1.03 0.16 2.42 × 10−11 1.08 × 10−10 FSHB
Sex hormone levels rs11031005 0.95 0.14 2.71 × 10−11 1.08 × 10−10 FSHB
Age at menopause rs11031005 −4.04 0.61 2.71 × 10−11 2.36 × 10−9 FSHB
Age at menarche rs11031006 −10.91 1.63 2.42 × 10−11 3.82 × 10−9 FSHB
Length of menstrual cycle rs11031006 −1.81 0.27 2.42 × 10−11 2.42 × 10−10 FSHB
SNP: Single Nucleotide Polymorphism; SE: Standard Error; FDR: False Discovery Rate; TSS: Transcriptional Start Site.
4. Discussion
To our knowledge, this is the first study that systematically assesses a shared genetic
origin between different associated phenotypes and endometriosis using a 2SMR approach.
In 2SMR studies, it is of outmost importance to carefully select the GWASs to be used as
exposure and as outcome data. Genetic instruments used as exposure, which encompass
a list of endometriosis-associated traits reported in literature, were extracted from public
GWAS repositories by applying three selection criteria. First, since the statistical power
of 2SMR analyses is determined by sample size, we prioritized genomic studies with the
largest number of individuals. Second, in order to guarantee the homogeneity of the
results, and to ensure the compatibility with the Finish cohort used as outcome, only
GWASs with European ancestry individuals were selected. Third, given that endometriosis
is a disease that affects only females, we tried to select GWASs carried out only in women,
something that was possible for all the selected phenotypes except for autoimmune diseases.
Regarding outcome data, since summary statistics from the largest case-control GWAS meta-
analysis on endometriosis performed up to date (17,045 cases and 191,596 controls) [33]
were not publicly available, we queried for public genomic data from large cohort studies.
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We discarded UKBB data to avoid the limitations associated with sample overlap with
some of the selected exposure datasets, and we finally selected the FinnGen cohort for
N14_ENDOMETRIOSIS phenotype comprising 3380 cases and 31,753 controls.
In order to study the selected phenotypes in a systematic manner, we analyzed the
overall 2SMR estimates combining all endometriosis risk SNPs. According to the literature,
there is a clear co-morbidity between autoimmune diseases and endometriosis. In our study,
we only found a significant association of endometriosis with MS, but our results went
in the opposite direction compared to most of the published literature [6,7], as it seemed
that genetic variants predisposing to one disease protect from the other. Nevertheless,
this was not a robust association since we only obtained a significant p-value with one
of the methods. In the rest of the cases, 2SMR analysis did not provide evidence of any
clear causal relationship between endometriosis and the selected autoimmune diseases,
and in all cases, effect sizes were close to zero. However, these data should be interpreted
with caution for several reasons. First, the sample sizes for the selected GWASs are rather
modest compared with the rest of the selected traits, limiting the power of the analysis.
Second, exposure GWASs used for these analyses included male and female individuals,
and endometriosis is a disorder only affecting women. Thus, it would be interesting to carry
out a similar analysis if female autoimmune GWASs become available in the future. Even
considering these caveats, our data are in line with a previous report describing the lack
of genetic correlation between endometriosis and autoimmune diseases [34], suggesting
that other molecular mechanisms might be mediating the link between these two types
of diseases.
The second category that we studied was a list of anthropometric traits, namely weight,
height, BMI and waist-to-hip ratio, which are inversely correlated with endometriosis,
according to the literature [9–13]. Our 2SMR analyses were in line with published reports,
as the effect sizes (ORs) for most of the traits and methods were below one, suggesting a
negative correlation between the exposure and outcome instrumental variables. Moreover,
in the case of weight and BMI, not only the effect sizes were below one, but a significant
association was also obtained in each case. These data are in line with the published
literature and point to a lesser weight or BMI mediating the genetic susceptibility to
suffer from endometriosis. Although due to the limited sample sizes we cannot confirm
causality or mediation, in the present work we have found common genetic roots affecting
predisposition to low weight or BMI and endometriosis.
The most appealing results from our 2SMR analysis derive from female reproductive
traits. In the case of hormones, overall estimates of AMH levels and endometriosis yielded
significant associations in two out of the three methods tested, with OR values below 1. It
is well known that endometriosis may affect ovarian reserve, and therefore AMH levels,
through mechanisms including ovarian injury that is caused by surgery [35]. However, our
work provides a new point of view, according to which there might be a shared genetic
origin between having low AMH levels and suffering from endometriosis, regardless
of the AMH decrease caused by the reduction of the ovarian reserve. For all the other
hormones tested, no significant associations with endometriosis were obtained. However,
we have to consider that in the GWAS that we used as exposure [28], only three SNPs were
significant, limiting the power of our analysis. Another possibility that might explain the
lack of significant associations might be that the aberrant hormone signaling observed
in women suffering from endometriosis might derive from a deregulation in hormone
receptors [16,36,37], rather than from altered blood hormone levels themselves.
For the remaining female reproductive traits analyzed, we obtained significant associ-
ations with endometriosis and ORs below one for age at menarche and length of menstrual
cycle, the latter yielding significant associations with all the employed methods. Our data
are in line with published literature describing increased endometriosis susceptibility with
a more prolonged exposure to menstruation [18,19]. Now, our data go further, and suggest
that shorter menstrual cycles could mediate the genetic susceptibility to endometriosis.
Again, we cannot discard that associated SNPs provide predisposition to both shorter
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menstrual cycles and endometriosis without a causal link between each other, but in any
case, we can confirm the existence of a common genetic basis.
Regarding particular SNPs associated to both endometriosis and different associated
traits, we have found that most of the prominent associations map to a region in chromo-
some 11, 25–40 Kb upstream of FSHB. In this context, in 2016 Ruth et al. showed that a
genetic variant in the same region is associated with low FSH levels and longer menstrual
cycles [38]. This association was also found for both nulliparity and endometriosis risk.
The authors concluded that FSH levels, genetically regulated by SNPs located upstream of
the FSHB promoter, can influence a number of menstrual cycle traits such as length and
menopause timing, but also reproductive outcomes, including infertility and endometriosis.
Our results confirm that this genomic locus is related in a complex way to a number of
female reproductive traits and affects female health outcomes and fertility.
One of the strengths of our 2SMR analysis is that it is carried out using public data.
The use of public data is an effective and efficient way to generate new hypotheses, to
validate the results and discoveries of previous unrelated works and to analyze existing
data with modest costs in order to explore uncovered conclusions. However, we have to
admit that this might also be a limitation. First, due to the limited sample sizes of existing
GWASs, and to the differing numbers of cases and controls in population studies. Second,
due to the fact that several of the GWASs used include males, while endometriosis studies
obviously do not. Last but not least, because most of GWASs have been performed in
people from European ancestry, and therefore caution should be taken when generalizing
our findings to the general, non-European populations. Thus, studies like ours should
be validated when more complete and powerful datasets become publicly available. In
addition, larger sample sizes will probably enable to perform pleiotropy tests and will
help distinguish causal associations or mediation from pleiotropic associations between
unrelated events.
5. Conclusions
This is the first work that systematically analyzes the putative common genetic origins
of endometriosis and a list of associated phenotypes using a 2SMR approach and public
data. Our study serves to pinpoint common genetic roots between endometriosis and
several female anthropometric and reproductive traits. Especially, we uncover a putative
genetic basis of reduced AMH levels in endometriotic women, regardless of ovarian injury,
and provide evidence that genetic variants that predispose to a more frequent exposure
to menstruation might also increase the risk to suffer from endometriosis. Finally, we
confirm the importance of the FSHB upstream region on different female menstrual traits
and reproductive outcomes, including endometriosis disease.
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